Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia

Kotaro Takasaki, Kanako Uchida, Risako Fujikawa, Ai Nogami, Kazuya Nakamura, Chihiro Kawasaki, Kazuko Yamaguchi, Masahiko Morita, Koji Morishita, Kaori Kubota, Shutaro Katsurabayashi, Kenichi Mishima, Michihiro Fujiwara, Katsunori Iwasaki

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Citidine-5-diphosphocholine or citicoline (CDP-choline) is used as a neuroprotective and memory-enhancing drug in cerebral stroke, Alzheimer's disease, and other neurovascular diseases. Non-clinical studies have demonstrated the neuroprotective effects of CDP-choline in ischemic animal models. However, the relationship between the neuroprotective effect and the memory enhancing effect of CDP-choline is still unknown. No studies have demonstrated the ameliorative effect on impaired spatial memory and the suppressive effect on neuronal cell death of CDP-choline in the same model. In this study, we examined the effect of CDP-choline on impaired spatial memory and hippocampal CA1 neuronal death in rats subjected to repeated cerebral ischemia, and we compared the mechanism of CDP-choline to that of donepezil. Seven days post administration of CDP-choline (100, 300, 1000 mg/kg per day, p.o.) or donepezil increased correct choices and reduced error choices in an eight-arm radial maze task in a dose-dependent manner. Neuronal cell death of caspase-3 protein-positive neurons in the hippocampus were reduced by repeated administration of CDP-choline at the highest dose. These results suggest that CDP-choline has ameliorative effects on the impairment of spatial memory via hippocampal neuronal cell death in a rat model of cerebral ischemia.

Original languageEnglish
Pages (from-to)232-237
Number of pages6
JournalJournal of Pharmacological Sciences
Volume116
Issue number2
DOIs
Publication statusPublished - Jun 24 2011

Fingerprint

Cytidine Diphosphate Choline
Neuroprotective Agents
Dementia
Cell Death
Brain Ischemia
Spatial Memory
Caspase 3
Hippocampus
Alzheimer Disease
Animal Models
Stroke

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia. / Takasaki, Kotaro; Uchida, Kanako; Fujikawa, Risako; Nogami, Ai; Nakamura, Kazuya; Kawasaki, Chihiro; Yamaguchi, Kazuko; Morita, Masahiko; Morishita, Koji; Kubota, Kaori; Katsurabayashi, Shutaro; Mishima, Kenichi; Fujiwara, Michihiro; Iwasaki, Katsunori.

In: Journal of Pharmacological Sciences, Vol. 116, No. 2, 24.06.2011, p. 232-237.

Research output: Contribution to journalArticle

Takasaki, K, Uchida, K, Fujikawa, R, Nogami, A, Nakamura, K, Kawasaki, C, Yamaguchi, K, Morita, M, Morishita, K, Kubota, K, Katsurabayashi, S, Mishima, K, Fujiwara, M & Iwasaki, K 2011, 'Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia', Journal of Pharmacological Sciences, vol. 116, no. 2, pp. 232-237. https://doi.org/10.1254/jphs.11013FP
Takasaki, Kotaro ; Uchida, Kanako ; Fujikawa, Risako ; Nogami, Ai ; Nakamura, Kazuya ; Kawasaki, Chihiro ; Yamaguchi, Kazuko ; Morita, Masahiko ; Morishita, Koji ; Kubota, Kaori ; Katsurabayashi, Shutaro ; Mishima, Kenichi ; Fujiwara, Michihiro ; Iwasaki, Katsunori. / Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia. In: Journal of Pharmacological Sciences. 2011 ; Vol. 116, No. 2. pp. 232-237.
@article{76034186d11f422580f74be398acae7d,
title = "Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia",
abstract = "Citidine-5-diphosphocholine or citicoline (CDP-choline) is used as a neuroprotective and memory-enhancing drug in cerebral stroke, Alzheimer's disease, and other neurovascular diseases. Non-clinical studies have demonstrated the neuroprotective effects of CDP-choline in ischemic animal models. However, the relationship between the neuroprotective effect and the memory enhancing effect of CDP-choline is still unknown. No studies have demonstrated the ameliorative effect on impaired spatial memory and the suppressive effect on neuronal cell death of CDP-choline in the same model. In this study, we examined the effect of CDP-choline on impaired spatial memory and hippocampal CA1 neuronal death in rats subjected to repeated cerebral ischemia, and we compared the mechanism of CDP-choline to that of donepezil. Seven days post administration of CDP-choline (100, 300, 1000 mg/kg per day, p.o.) or donepezil increased correct choices and reduced error choices in an eight-arm radial maze task in a dose-dependent manner. Neuronal cell death of caspase-3 protein-positive neurons in the hippocampus were reduced by repeated administration of CDP-choline at the highest dose. These results suggest that CDP-choline has ameliorative effects on the impairment of spatial memory via hippocampal neuronal cell death in a rat model of cerebral ischemia.",
author = "Kotaro Takasaki and Kanako Uchida and Risako Fujikawa and Ai Nogami and Kazuya Nakamura and Chihiro Kawasaki and Kazuko Yamaguchi and Masahiko Morita and Koji Morishita and Kaori Kubota and Shutaro Katsurabayashi and Kenichi Mishima and Michihiro Fujiwara and Katsunori Iwasaki",
year = "2011",
month = "6",
day = "24",
doi = "10.1254/jphs.11013FP",
language = "English",
volume = "116",
pages = "232--237",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8613",
publisher = "Japanese Pharmacological Society",
number = "2",

}

TY - JOUR

T1 - Neuroprotective effects of citidine-5-diphosphocholine on impaired spatial memory in a rat model of cerebrovascular dementia

AU - Takasaki, Kotaro

AU - Uchida, Kanako

AU - Fujikawa, Risako

AU - Nogami, Ai

AU - Nakamura, Kazuya

AU - Kawasaki, Chihiro

AU - Yamaguchi, Kazuko

AU - Morita, Masahiko

AU - Morishita, Koji

AU - Kubota, Kaori

AU - Katsurabayashi, Shutaro

AU - Mishima, Kenichi

AU - Fujiwara, Michihiro

AU - Iwasaki, Katsunori

PY - 2011/6/24

Y1 - 2011/6/24

N2 - Citidine-5-diphosphocholine or citicoline (CDP-choline) is used as a neuroprotective and memory-enhancing drug in cerebral stroke, Alzheimer's disease, and other neurovascular diseases. Non-clinical studies have demonstrated the neuroprotective effects of CDP-choline in ischemic animal models. However, the relationship between the neuroprotective effect and the memory enhancing effect of CDP-choline is still unknown. No studies have demonstrated the ameliorative effect on impaired spatial memory and the suppressive effect on neuronal cell death of CDP-choline in the same model. In this study, we examined the effect of CDP-choline on impaired spatial memory and hippocampal CA1 neuronal death in rats subjected to repeated cerebral ischemia, and we compared the mechanism of CDP-choline to that of donepezil. Seven days post administration of CDP-choline (100, 300, 1000 mg/kg per day, p.o.) or donepezil increased correct choices and reduced error choices in an eight-arm radial maze task in a dose-dependent manner. Neuronal cell death of caspase-3 protein-positive neurons in the hippocampus were reduced by repeated administration of CDP-choline at the highest dose. These results suggest that CDP-choline has ameliorative effects on the impairment of spatial memory via hippocampal neuronal cell death in a rat model of cerebral ischemia.

AB - Citidine-5-diphosphocholine or citicoline (CDP-choline) is used as a neuroprotective and memory-enhancing drug in cerebral stroke, Alzheimer's disease, and other neurovascular diseases. Non-clinical studies have demonstrated the neuroprotective effects of CDP-choline in ischemic animal models. However, the relationship between the neuroprotective effect and the memory enhancing effect of CDP-choline is still unknown. No studies have demonstrated the ameliorative effect on impaired spatial memory and the suppressive effect on neuronal cell death of CDP-choline in the same model. In this study, we examined the effect of CDP-choline on impaired spatial memory and hippocampal CA1 neuronal death in rats subjected to repeated cerebral ischemia, and we compared the mechanism of CDP-choline to that of donepezil. Seven days post administration of CDP-choline (100, 300, 1000 mg/kg per day, p.o.) or donepezil increased correct choices and reduced error choices in an eight-arm radial maze task in a dose-dependent manner. Neuronal cell death of caspase-3 protein-positive neurons in the hippocampus were reduced by repeated administration of CDP-choline at the highest dose. These results suggest that CDP-choline has ameliorative effects on the impairment of spatial memory via hippocampal neuronal cell death in a rat model of cerebral ischemia.

UR - http://www.scopus.com/inward/record.url?scp=79959369914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959369914&partnerID=8YFLogxK

U2 - 10.1254/jphs.11013FP

DO - 10.1254/jphs.11013FP

M3 - Article

C2 - 21613753

AN - SCOPUS:79959369914

VL - 116

SP - 232

EP - 237

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8613

IS - 2

ER -